Published by Frank Prenesti on 2nd November 2022
(Sharecast News) - UK pharma giant GSK lifted full-year guidance after beating third-quarter expectations with an 18% rise in revenues driven by its Shingrix shingles treatment.
URL: http://www.digitallook.com/dl/news/story/33078571/...